Anjan Drugs

  • Industry: Pharmaceuticals
  • Status: Realised (2018)
  • Year of investment: 2009

Anjan Drugs

Anjan is a leading supplier of active pharmaceutical ingredients (APIs) in the central nervous system (CNS) therapy segment to some of the world’s largest pharmaceutical companies, in markets including the U.S.,Canada, LATAM and Europe.

With two state-of-the art USFDA approved manufacturing facilities, Anjan is one of the global leaders in the manufacture and supply of valproic acid family of salts.

Anjan’s strong green chemistry capabilities enhances quality and enables cost leadership.

Scroll to top